申请人:Dainippon Sumitomo Pharma Co., Ltd.
公开号:EP1844768A1
公开(公告)日:2007-10-17
The present invention provides a compound represented by the following formula (I):
[wherein, A represents a group of the following formula (A-1):
etc., R1 and R2 each independently represent a hydrogen atom etc., Z represents CR3 etc., W represents CR4 etc., Q represents CR5 etc., R3, R4 and R5 each independently represent a hydrogen atom etc., Y represents an oxygen atom or sulfur atom, X represents an oxygen atom etc. and B represents an optionally substituted aryl group or optionally substituted heteroaryl group], the prodrug thereof or the pharmaceutically acceptable salt thereof for preventing or treating various diseases such as hypertesion, cerebral stroke, cardiac failure, etc.
本发明提供了以下式(I)所表示的化合物:
[其中,A表示以下式(A-1)的基团:
等等,R1和R2分别独立表示氢原子等,Z表示CR3等,W表示CR4等,Q表示CR5等,R3、R4和R5分别独立表示氢原子等,Y表示氧原子或硫原子,X表示氧原子等,B表示可选择地取代的芳基或可选择地取代的杂环基],其前药或其药学上可接受的盐,用于预防或治疗高血压、脑卒中、心力衰竭等各种疾病。